1-15 of 15
Ingrid Lafon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Tolerance of Brexucabtagene Autoleucel in Adults with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia : A Graall Study from the Descar-T Registry

Florence Rabian, David Beauvais, Tony Marchand, Sabine Furst, Anne Huynh, Eolia Brissot, Sebastien Maury, Ludovic Gabellier, Patrice Chevallier, Michael Loschi, Stéphanie Nguyen Quoc, Marie Balsat, Ingrid Lafon, Amandine Fayard, Vincent Camus, Célestine Simand, Niels Moya, Cristina Castilla-Llorente, Magalie Joris, Ana Berceanu, Anne Thiebaut, Véronique Lhéritier, Eve Gehlkopf, Gabrielle Roth-Guepin, Thibaut Leguay, Nicolas Boissel
Journal: Blood
Blood (2023) 142 (Supplement 1): 3498.
https://doi.org/10.1182/blood-2023-180575
Published: 2023
Journal Articles

French Early Nationwide Idecabtagene Vicleucel (Ide-Cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy Experience in Patients with Relapsed/Refractory Multiple Myeloma (FENIX): Update of the IFM Study from the Descar-T Registry

Sarah Cayla, Benoit Ferment, Noemie Bigot, Denis Caillot, Ingrid Lafon, Lionel Karlin, Anne Lazareth, Cyrille Touzeau, Xavier Leleu, Niels Moya, Stephanie Harel, Aurore Perrot, Pierre Bories, Laure Vincent, Sylvain Lamure, Mohamad Mohty, Florent Malard, Salomon Manier, Ibrahim Yakoub-Agha, Anne-Marie Stoppa, Gabriel Brisou, Olivier Decaux, Roch Houot, Steven Le Gouill, Jerome Lambert, Thierry Facon, Herve Avet Loiseau, Philippe Moreau, Bertrand Arnulf
Journal: Blood
Blood (2023) 142 (Supplement 1): 2139.
https://doi.org/10.1182/blood-2023-188655
Published: 2023
Journal Articles

Frontline Consolidation with Nelarabine for Adults with High-Risk T-Cell Acute Lymphoblastic Leukemia. Results of the Graall-2014/T Atriall Phase 2 Study

Nicolas Boissel, Carlos Graux, Francoise Huguet, Florence Pasquier, Aurore Touzart, Thomas Cluzeau, Ludovic Lhermitte, Eric Delabesse, Patrice Chevallier, Mathilde Hunault, Cedric Pastoret, Sebastien Maury, Nathalie Grardel, Martine Escoffre Barbe, Pascal Turlure, Beat Schafer, Marie Balsat, Philippe Rousselot, Thibaut Leguay, Eric Jourdan, Delphine Pranger, Michael Gregor, Emilie Lemasle, Anne Marie Ronchetti, Ana Berceanu, Ingrid Lafon, Madalina Uzunov, Etienne Lengline, Norbert Ifrah, Yves Chalandon, Véronique Lhéritier, Vahid Asnafi, Herve Dombret
Journal: Blood
Blood (2023) 142 (Supplement 1): 962.
https://doi.org/10.1182/blood-2023-177696
Published: 2023
Journal Articles

French Early Nationwide Idecabtagene Vicleucel (Ide-Cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy Experience in Patients with Relapsed/Refractory Multiple Myeloma (FENIX): An IFM Study from the Descar-T Registry

Benoit Ferment, Jérôme Lambert, Denis Caillot, Ingrid Lafon, Lionel Karlin, Anne Lazareth, Cyrille Touzeau, Xavier Leleu, Niels Moya, Stephanie Harel, Aurore Perrot, Pierre Bories, Laure Vincent, Sylvain Lamure, Mohamad Mohty, Florent Malard, Salomon Manier, Ibrahim Yakoub-Agha, Anne-Marie Stoppa, Gabriel Brisou, Olivier Decaux, Roch Houot, Steven Le Gouill, Thierry Facon, Hervé Avet-Loiseau, Philippe Moreau, Bertrand Arnulf
Journal: Blood
Blood (2022) 140 (Supplement 1): 4668–4670.
https://doi.org/10.1182/blood-2022-162682
Published: 2022
Journal Articles

Phase II Study of the Combination of Pomalidomide with Dexamethasone As Maintenance Therapy after First Relapse Treatment with PCD Followed or Not By Autologous Stem Cell Transplant in Multiple Myeloma Patients

Laurent Garderet, Frédérique Kuhnowski, Benoit Berge, Murielle Roussel, Martine Escoffre-Barbe, Ingrid Lafon, Thierry Facon, Xavier Leleu, Lionel Karlin, Aurore Perrot, Philippe Moreau, Gerald Marit, Anne-Marie Stoppa, Bruno Royer, Carine Chaleteix, Mourad Tiab, Carla Araujo, Pascal Lenain, Margaret Macro, Eric G. Voog, Lotfi Benboubker, Olivier Thierry Allangba, Eric Jourdan, Frédérique Orsini-Piocelle, Sabine Brechignac, Jean-Richard Eveillard, Karim Belhadj, Marc Wetterwald, Brigitte Pegourie, Arnaud Jaccard, Jean Claude Eisenmann, Sylvie Glaisner, Mohamad Mohty, Cyrille Hulin, Herve Avet Loiseau, Claire Mathiot, Michel Attal
Journal: Blood
Blood (2021) 138 (Supplement 1): 2753.
https://doi.org/10.1182/blood-2021-152136
Published: 2021
Journal Articles

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma

Clinical Trials & Observations
Laurent Garderet, Frederique Kuhnowski, Benoit Berge, Murielle Roussel, Martine Escoffre-Barbe, Ingrid Lafon, Thierry Facon, Xavier Leleu, Lionel Karlin, Aurore Perrot, Philippe Moreau, Gerald Marit, Anne-Marie Stoppa, Bruno Royer, Carine Chaleteix, Mourad Tiab, Carla Araujo, Pascal Lenain, Margaret Macro, Eric Voog, Lofti Benboubker, Olivier Allangba, Eric Jourdan, Frederique Orsini-Piocelle, Sabine Brechignac, Jean-Richard Eveillard, Karim Belhadj, Marc Wetterwald, Brigitte Pegourie, Arnaud Jaccard, Jean-Claude Eisenmann, Sylvie Glaisner, Mohamad Mohty, Cyrille Hulin, Herve Avet Loiseau, Claire Mathiot, Michel Attal
Journal: Blood
Blood (2018) 132 (24): 2555–2563.
https://doi.org/10.1182/blood-2018-07-863829
Published: 2018
Includes: Supplemental data
Journal Articles

A Multicenter Open Label Phase II Study of Pomalidomide, Cyclophosphamide and Dexamethasone in Relapse Multiple Myeloma Patients Initially Treated with Lenalidomide, Bortezomib and Dexamethasone

Laurent Garderet, MD PhD, Frederique Kuhnowski, MD, jean Yves Mary, MD, Murielle Roussel, Martine Escoffre-Barbe, MD, Ingrid Lafon, MD, Thierry Facon, MD, Lionel Karlin, MD, Aurore Perrot, MD, Philippe Moreau, MDPhD, Gerald Marit, MD, Anne-Marie Stoppa, MD, Jean-Pierre Marolleau, MD PhD, Carine Chaleteix, MD, Mourad Tiab, Carla Araujo, MD, Pascal Lenain, MD, Margaret Macro, MD, Eric Voog, MD, Lofti Benboubker, MD, Olivier Allangba, MD, Eric Jourdan, MD, Mohamad Mohty, MD PhD, Herve Avet Loiseau, MD PhD, Claire Mathiot, MD, Michel Attal, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 837.
https://doi.org/10.1182/blood.V130.Suppl_1.837.837
Published: 2017
Journal Articles

Comparison Of Hevylite™ Assay and Plasma Cell Immunophenotyping For Response Evaluation and Residual Disease Characterisation In IgA Myeloma

Daniela Lakomy, Stephanie Lemaire-Ewing, Cedric Rossi, Jessica Borgeot, Jean-Noël Bastie, Ingrid Lafon, Marc Maynadie, Denis Caillot, MD, Julien Guy
Journal: Blood
Blood (2013) 122 (21): 5319.
https://doi.org/10.1182/blood.V122.21.5319.5319
Published: 2013
Journal Articles

Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial

Clinical Trials & Observations
Thorsten Braun, Raphael Itzykson, Aline Renneville, Benoit de Renzis, François Dreyfus, Kamel Laribi, Krimo Bouabdallah, Norbert Vey, Andrea Toma, Christian Recher, Bruno Royer, Bertrand Joly, Anne Vekhoff, Ingrid Lafon, Laurence Sanhes, Guillaume Meurice, Cédric Oréar, Claude Preudhomme, Claude Gardin, Lionel Ades, Michaela Fontenay, Pierre Fenaux, Nathalie Droin, Eric Solary, on behalf of the Groupe Francophone des Myélodysplasies
Journal: Blood
Blood (2011) 118 (14): 3824–3831.
https://doi.org/10.1182/blood-2011-05-352039
Published: 2011
Includes: Supplemental data
Journal Articles

A Phase II Study of Decitabine In Advanced Chronic Myelomonocytic Leukemia (CMML)

Thorsten Braun, Nathalie Droin, Benoit de Renzis, Francois Dreyfus, Kamel Laribi, Krimo Bouabdallah, Aude Charbonnier, Catherine Cordonnier, Ingrid Lafon, Christian Récher, Norbert Vey, Jean-Noel M. Bastie, A. Besancon, Odile Beyne-Rauzy, Bertrand Joly, Eric Jourdan, Laurence Legros, Zora Marjanovic, Charlotte Petitdidier, Bruno Royer, Laurence Sanhes, Gerard Tertian, Ioana Vaida, Xavier Vallantin, Anne Vekhoff, Marina Milic, Raphael Itzykson, Claude Gardin, Lionel Ades, Pierre Fenaux, Eric Solary
Journal: Blood
Blood (2010) 116 (21): 1873.
https://doi.org/10.1182/blood.V116.21.1873.1873
Published: 2010
Journal Articles

The 18F-FDG SUVmax Reduction After Two Cycles of R-CHOP Regimen Predicts Progression Free Survival of Patients with Diffuse Large B-Cell Lymphoma.

Rene-Olivier Casasnovas, MD, Anne Laure Saverot, MD, Alina Berriolo-Riedinger, MD, Michel Toubeau, MD, Emmanuelle Ferrant, MD, Ingrid Lafon, MD, Denis Caillot, MD, Jean-Marc Riedinger, MD, Alexandre Cochet, MD, Inna Cochet, Jean-Noël Bastie, MD, PhD, Eric Solary, MD, PhD, Francois Brunotte, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2931.
https://doi.org/10.1182/blood.V114.22.2931.2931
Published: 2009
Journal Articles

Myelodysplastic Syndrome (MDS) in France: Results of a One-Week Cross-Sectional Survey on Daily Practice Management in 919 Patients by the GFM

C. Kelaidi, Aspasia Stamatoullas, Odile Beyne-Rauzy, Francois Dreyfus, Bruno Quesnel, Agnes Guerci, E. Raffoux, S. Brechignac, D. Vassilieff, T. Prebet, Yosr Hicheri, Laurence Legros, MP Chaury, H. Zerazhi, J. Camo, Christian Berthou, M. Hacini, Anne-Laure Taksin, Jacques Delaunay, B. Choufi, Ingrid Lafon, S. Ame, G. Dine, Stéphane Cheze, K. Ghomari, Pierre Fenaux
Journal: Blood
Blood (2008) 112 (11): 2672.
https://doi.org/10.1182/blood.V112.11.2672.2672
Published: 2008
Journal Articles

Incidence and Prognostic Value of FLT-3 and NPM1 Genes Abnormalities in Acute Myeloid Leukemia in the Côte D’or Population, France

Marc Maynadié, MD, PhD, Martine Courtois, Morgane Mounier, Ines Janoray-Manivet, Ingrid Lafon, Julien Guy, Paule-Marie Carli, François Girodon
Journal: Blood
Blood (2008) 112 (11): 4873.
https://doi.org/10.1182/blood.V112.11.4873.4873
Published: 2008
Journal Articles

Frequent Reduction or Absence of Detection of the JAK2 -Mutated Clone in JAK2V617F -Positive Patients within the First Years of Hydroxyurea Therapy

François Girodon, C.éline Schaeffer, C.édric Cleyrat, Morgane Mounier, Ingrid Lafon, FréD.éric Dos Santos, Aurélie Duval, Marc Maynadie, MD, PhD, Sylvie Hermouet
Journal: Blood
Blood (2008) 112 (11): 5225.
https://doi.org/10.1182/blood.V112.11.5225.5225
Published: 2008
Journal Articles

Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-Asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study.

Mathilde Hunault-Berger, MD-PhD, Yves Gruel, MD, Jean-Luc Harousseau, MD, Martine Delain, MD, Abdallah Maakaroun, MD, Claude-Eric Bulabois, MD, Francis Witz, MD, Marc Bernard, MD, Ingrid Lafon, Jerome Cornillon, MD, Abdel Ladouzi, Alexandra Tizon, Bruno Padrazzi, Zera Tellier, MD, Norbert Ifrah, MD, the GOELAMS group
Journal: Blood
Blood (2004) 104 (11): 4486.
https://doi.org/10.1182/blood.V104.11.4486.4486
Published: 2004